Neuronetics (STIM) Misses Q2 EPS by 7c ; Offers Guidance

Neuronetics (NASDAQ: STIM) reported Q2 EPS of ($0.15), $0.07 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $38.11 million versus the consensus estimate of $36.59 million.

GUIDANCE:

Neuronetics sees Q3 2025 revenue of $37-39 million, versus the consensus of $38.22 million.

Neuronetics sees FY2025 revenue of $149-155 million, versus the consensus of $151 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.

You May Also Be Interested In

• Citi Adds Four Names to Catalyst Call List
• Wolfe Research Starts SLB (SLB) at Outperform, 'lowest risk option on a selective capital cycle'
• Wolfe Research Starts Baker Hughes (BKR) at Outperform, 'FcF trajectory being mispriced at an OFS multiple'